Tags : Hospitalized Patients

Eli Lilly and Incyte’s Olumiant + Gilead’s Veklury Reduce Time

Shots: Eli Lilly and Incyte report the initial result of NIAID sponsored ACTT-2 study assessing the efficacy and safety of Olumiant (baricitinib, 4mg) + Veklury (remdesivir) vs Veklury as monothx. in hospitalized patients with COVID-19 The study met its EPs i.e. it demonstrated 1day reduction in median recovery time for the overall patient population and […]Read More

Abbott’s Freestyle Libre System Receives Health Canada Authorization Under Interim

Shots:Shots: Health Canada has authorized the use of Abbott’s FreeStyle Libre system in the hospital amid COVID-19. The authorization will allow HCPs to remotely monitor patients’ glucose status to minimize exposure during COVID-19 and preserve the use of PPE Additionally, Abbott will donate ~3,000 FreeStyle Libre sensors to provide immediate access to the hospital. The […]Read More